OTCMKTS:PXXLF Poxel (PXXLF) Stock Price, News & Analysis → Have You Seen Elon’s New A.I. Device? (Picture Inside) (From InvestorPlace) (Ad) Free PXXLF Stock Alerts $0.70 0.00 (0.00%) (As of 04/30/2024 ET) Add Compare Share Share Today's Range$0.70▼$0.7050-Day Range$0.55▼$0.7052-Week Range$0.55▼$0.70VolumeN/AAverage Volume5 shsMarket Capitalization$20.27 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Poxel alerts: Email Address Ad MillPub😱 This phenomenon is smashing regular market gainsThanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.Click here to save your seat and join the next LIVE workshop! About Poxel Stock (OTCMKTS:PXXLF)Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats chronic metabolic diseases, including diseases that affect the liver, such as non-alcoholic steatohepatitis (NASH); PXL065, an earlier stage programs that is in Phase 2 for the treatment of NASH focusing on chronic and rare metabolic indications. The company has a licensing agreement with Enyo Pharma S.A.S. for the development of farnesoid X receptor that is in Phase 2a study for the treatment of hepatitis B and NASH; and DeuteRx LLC for the development of PXL065, a mitochondrial pyruvate carrier inhibitor, which is in a phase I clinical trial for the treatment of NASH. Poxel S.A. was incorporated in 2009 and is headquartered in Lyon, France.Read More PXXLF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PXXLF Stock News HeadlinesApril 30, 2024 | msn.comThis highly rated game has arrived on Xbox Game PassApril 29, 2024 | businesswire.comPoxel Provides a Financial Update for the First Quarter 2024 and Announces the Postponement of its 2023 Full-Year Results ReleaseMay 1, 2024 | MillPub (Ad)😱 This phenomenon is smashing regular market gainsThanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.April 29, 2024 | msn.comGoogle Pixel 8A ad leak confirms most rumors weeks before launchApril 28, 2024 | msn.com10 Best Video Games Coming Out In May 2024April 27, 2024 | mirror.co.uk7 best indie games released in April 2024 – don't sleep on these overlooked gemsApril 26, 2024 | yahoo.comWalton County kids practice motor skills at Special Olympics YAP eventApril 26, 2024 | yahoo.comCould Bob Graham succeed in current political climate?May 1, 2024 | MillPub (Ad)😱 This phenomenon is smashing regular market gainsThanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.April 26, 2024 | msn.comEpic Games Store: New Free Game of the Week Revealed (April 25)April 25, 2024 | msn.comNintendo 3DS: Why It Rules As The Ultimate HandheldApril 20, 2024 | msn.comAndroid phones are getting a powerful parental control upgradeApril 19, 2024 | msn.com9 Fantastic Co-Op Cozy Games for CouplesApril 18, 2024 | msn.comHere's Everything From April 2024's Indie World ShowcaseApril 13, 2024 | msn.comAmazon’s Fallout TV series is even more impressive than The Last of UsApril 12, 2024 | msn.comBest Nintendo Switch Games in 2024April 10, 2024 | msn.comPlayStation Plus Game Catalog Additions for April 2024 RevealedApril 9, 2024 | msn.comWordle Answer Today (April 2024) - Solution History!April 7, 2024 | msn.comTop Amazon deals: Super Buy 2 Get 1 Free sale on books, games and DVDs, iPhone Charging Cords 3 Pk only $5.99April 2, 2024 | msn.comIn defense of Stardew Valley’s fantastically frustrating fishingApril 2, 2024 | msn.comPixel Washer will have you jet-washing those sprites until they are cleanApril 2, 2024 | msn.comWhat's the Answer to Today's Wordle? (April 2024)April 1, 2024 | msn.com10 addictive Android games to playMarch 30, 2024 | businessinsider.comThe best Google Pixel 8 Pro cases in 2024March 29, 2024 | msn.comWhy Tater Tots Always Taste Better At A Restaurant Than At HomeMarch 28, 2024 | msn.com12 Games Set In Ancient ChinaMarch 28, 2024 | msn.comGoogle reverses course and brings its Gemini AI to the regular Pixel 8See More Headlines Receive PXXLF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Poxel and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private households Sub-IndustryN/A Current SymbolOTCMKTS:PXXLF CUSIPN/A CIKN/A Webwww.poxel.com Phone33-4-37-37-20-10Fax043-770-8815Employees15Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$710,000.00 Price / Sales28.54 Cash FlowN/A Price / Cash FlowN/A Book Value($0.66) per share Price / Book-1.06Miscellaneous Outstanding Shares28,950,000Free FloatN/AMarket Cap$20.27 million OptionableNot Optionable Beta0.53 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Thomas Kuhn M.B.A.Pharm D MBA, Pharm.D., Co-Founder, CEO & DirectorDr. Sébastien Bolze Ph.D.Pharm D Ph.D., Pharm.D., Co-Founder, COO and Executive VP of Project Management, Non Clinical & Manufacturing OperationsDr. Pascale Fouqueray-Grellier M.D.Ph.D., Co-Founder and Executive VP of Clinical Development & Regulatory AffairsDr. Sophie Hallakou-Bozec Ph.D.Co-Founder and Executive VP of R&D Pharmacology & Scientific CommunicationArthur RouilleInvestor Relations OfficerMr. Quentin DurandExecutive VP, Chief Legal Officer & Head of Corporate Social ResponsibilityMs. Sylvie BertrandVice President of Human ResourcesMore ExecutivesKey CompetitorsNicoxOTCMKTS:NICXFElse NutritionOTCMKTS:BABYFPreveCeutical MedicalOTCMKTS:PRVCFNantHealthNASDAQ:NHIQLexaria BioscienceOTCMKTS:LXRPView All Competitors PXXLF Stock Analysis - Frequently Asked Questions How have PXXLF shares performed in 2024? Poxel's stock was trading at $0.60 at the start of the year. Since then, PXXLF stock has increased by 16.7% and is now trading at $0.70. View the best growth stocks for 2024 here. How do I buy shares of Poxel? Shares of PXXLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PXXLF) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersElon’s New A.I. Device is About to Shock the WorldInvestorPlaceAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Report😱 This phenomenon is smashing regular market gainsMillPubThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersYour bank is lying to you.MyBankTrackerThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBanking Apocalypse Ahead: Secure Your Savings Today!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Poxel S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
